Sateesh C. Babu, MDProfessor of Surgery
New York Medical College
Attending Vascular Surgeon
Westchester Medical Center
Valhalla, New York
SATEESH C. BABU, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 19: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS - MEDICAL AND NATURAL HISTORY ISSUES'Low-Flow State' Induced Limb Ischemia: What’s The Etiology: Is The Incidence Increasing In The Era Of ECMO, IMPELLA, LVADs And Heart Transplantation: How Should It Be Treated
1:36 PM - 1:41 PM
Thursday, November 21, 2024
Session ModeratorSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27) PresenterSESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES Disseminated Fungal Infections Of The Vascular System: Why Are They Important And How Should They Be Diagnosed And Treated
5:26 PM - 5:31 PM
![](/faculty_photos_large/2199.jpg)
Martin R. Back, MDProfessor of Surgery
University of Florida
Chief
Division of Vascular Surgery
Gainesville, Florida
MARTIN R. BACK, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGYUse Of TEVARs For TBAD In Patients With Connective Tissue Disease: When Should They Be Done: How Durable Are They And When Are Open Repairs Better
3:56 PM - 4:01 PM
Thursday, November 21, 2024
PresenterSESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS Why Is A Distal AUI The Preferred Approach For ZFEN F/EVAR Treatment Of Failed EVAR Devices: When And How To Do It And Outcomes
10:32 AM - 10:37 AM
Friday, November 22, 2024
PresenterSESSION 87: POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMAEndovascular Versus Open Repair: Why After 20 Years Of Selective Endografting, I Now Favor Open Repair In Most Patients
7:04 AM - 7:09 AM
MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
OPEN VASCULAR TECHNIQUES
FRIDAY, NOVEMBER 22, 2024
PRESENTER
3:07 PM – 3:14 PM
Subclavian to Carotid Transposition
![](/img/white75x75.jpg)
Mirza S. Baig, MDClinical Associate Professor of Surgery
University of Texas Southwestern Medical School.
Clinical Associate Professor
Clements University Hospital
Dallas, Texas
Charles J. Bailey, MDAssistant Professor of Surgery
University of South Florida
Director, Limb Preservation-PAD Program
Tampa General Hospital
Tampa, Florida
Amanda Baker, MDAssistant Professor in Radiology and Neurosurgery
Albert Einstein Medical School
Attending
Montefiore Medical Center
Bronx, New York
Jonathan Bath, MDAssociate Professor of Surgery
University of Missouri
Program Director for Vascular Fellowship
University of Missouri
Columbia, Missouri
Iris Baumgartner, MDProfessor of Internal Medicine & Angiology
Vasc Alliance AG, Hirslanden Clinic
Attending Doctor
Attending Doctor & Co-Founder Vasc Alliance
Bern, Switzerland
IRIS BAUMGARTNER, MD - SCHEDULE FOR VEITHsymposium™
Friday, November 22, 2024
PresenterSESSION 96: VENOUS STENT TRIALS Criteria To Predict Mid-Term Outcome After Stenting Of Chronic Iliac Vein Obstructions (PROMISE Trial)
8:41 AM - 8:46 AM
![](/faculty_photos_large/3594.jpg)
Hernan A. Bazan, MD, DFSVS, FACSJohn Ochsner Endowed Professor of Surgery, Section of Vascular/Endovascular Surgery
Ochsner Clinic
Program Director, Vascular Surgery Fellowship
Ochsner Clinic
New Orleans, Louisiana
HERNAN A. BAZAN, MD, DFSVS, FACS - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 11: MORE ABOUT CAROTID DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKESHow Should Acute Stroke Severity (NIHSS) Influence Timing To Therapeutic Intervention: For TPA Use; For CEA And CAS; For Intracranial Arterial Clot Removal: It Matters To Neurologic Outcomes
10:16 AM - 10:21 AM
Friday, November 22, 2024
PresenterSESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONSWhen Is Urgent (Within 48 Hours) CEA Or CAS Fairly Indicated After A Stroke: How Does Use Of tPA Influence Indications And Neurologic Outcomes In This Setting
11:36 AM - 11:41 AM
![](/faculty_photos_large/4106.jpg)
![](/img/white75x75.jpg)
![](/faculty_photos_large/3744.jpg)
Adam Beck, MDDivision Director Vascular Surgery and Endovascular Therapy
University of Alabama at Birmingham
Professor of Surgery
UAB Medicine
Birmingham, Alabama
ADAM BECK, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE Current Status of The Relay Ascending Aortic Endograft From Terumo: What Makes It Different
9:02 AM - 9:07 AM
Thursday, November 21, 2024
PresenterSESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS Prediction Of 1-Year Mortality After Endovascular TAAA Repair: When Should We NOT Offer The Procedure
10:02 AM - 10:07 AM
Friday, November 22, 2024
Session ModeratorSESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMSPresenterSESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMSPrevention Of SCI After Endovascular TAAA Repairs: Lessons Learned From The US Aortic Research Consortium (ARC)
7:34 AM - 7:39 AM
MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
VASCULAR FELLOWS & RESIDENTS CAREER DEVELOPMENT PROGRAM
FRIDAY, NOVEMBER 22, 2024
PRESENTER
9:23 AM - 9:31 AM
Do I Need To Do An Added Fellowship In Advanced Aortic Interventions Before Starting My First Job
![](/faculty_photos_large/1891.jpg)
Christian A. Behrendt, MDAssociate Professor
Asklepios Medical School Hamburg
Department Head, Chief of Vascular and Endovascular Surgery
Asklepios Clinic Hamburg Wandsbek, Department of Vascular and Endovascular Surgery
Hamburg, Germany
![](/faculty_photos_large/2438.jpg)
James F. Benenati, MDClinical Professor of Radiology
Florida International University Herbert Wertheim College of Medicine
CMO
Penumbra Inc
Miami, Florida
![](/faculty_photos_large/4498.jpg)
Janna Bentley, MDMedical Director
Lakeshore Vein & Aesthetics Clinic
British Columbia, Canada
![](/faculty_photos_large/2420.jpg)
![](/faculty_photos_large/1895.jpg)
Ramon Berguer, MD, PhDEmeritus Professor of Surgery & Engineering
University of Michigan
Ann Arbor, Michigan
RAMON BERGUER, MD, PHD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAS) Update On The Current Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections By Cutting The Septum From Below: Yes, There Is A Downside To Other Septotomies That Cut The Septum From Above
11:30 AM - 11:35 AM
Wednesday, November 20, 2024
Session ModeratorSESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
OPEN VASCULAR TECHNIQUES
FRIDAY, NOVEMBER 22, 2024
PRESENTER
3:14 PM - 3:21 PM
Vertebral to Carotid Transposition
![](/faculty_photos_large/3496.jpg)
Colin D. Bicknell, MD, FRCSClinical Reader
Imperial College London
Consultant
Imperial College Healthcare NHS Trust
London, United Kingdom
![](/faculty_photos_large/3140.jpg)
Jean Bismuth, MDProfessor
University of South Florida
Professor
Tampa General Hospital
Tampa, Florida
JEAN BISMUTH, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 9: PROGRESS IN WEARABLE VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATIONRemote Measurement Of Blood Flow In Any Artery Or Graft Using An Implantable Ultrasonic Sensor With Transmission To The Internet (From IntelVasc): How Does It Work, And Experimental Data
6:56 AM - 7:01 AM
Thursday, November 21, 2024
PresenterSESSION 58: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH AND TAAAS (SEE ALSO SESSIONS 1, 2, 3 AND 40 FOR RELATED TOPICS)Changes In The Aortic Valve And Aortic Morphometrics After Ascending Aorta And Arch Endograft Placement: Why Are They Important And How Can They Be Avoided
11:24 AM - 11:29 AM
![](/faculty_photos_large/2713.jpg)
Martin Björck, MD, PhDProfessor of Vascular Surgery
Department of Surgical Sciences
Consultant
Section of Vascular Surgery
University Hospital
Uppsala, Sweden
MARTIN BJöRCK, MD, PHD - SCHEDULE FOR VEITHsymposium™
Thursday, November 21, 2024
Session ModeratorSESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS, COMPLEX AAAS, TAAAS AND RELATED TOPICS PresenterSESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS, COMPLEX AAAS, TAAAS AND RELATED TOPICS Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen
1:42 PM - 1:47 PM
Friday, November 22, 2024
Session ModeratorSESSION 87: POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMAPresenterSESSION 87: POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMATreatment Of Popliteal Aneurysms: When Conservative, When Open, When Endovascular: What Are The Hard Data
6:58 AM - 7:03 AM
PresenterSESSION 93: BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help
3:00 PM - 3:05 PM
Power Point Presentation with Synched Audio
![](/faculty_photos_large/3210.jpg)
James H. Black, III, MDThe David Goldfarb, MD Professor of Surgery
The Johns Hopkins University School of Medicine
Chief and Regional Director of Vascular Surgery and Endovascular Therapy
The Johns Hopkins Hospital and Johns Hopkins Medicine
Baltimore, Maryland
JAMES H. BLACK, III, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session ModeratorSESSION 16: UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)PresenterSESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE High Risk Features Of TEVAR For TBAD: Did The AHA Guidelines Get Them Right: TEVAR Outcomes For TBAD Are Worse Than For Degenerative Aneurysms
9:56 AM - 10:01 AM
PresenterSESSION 16: UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)Strategies And Technical Challenges In The Open Treatment Of Large TAAAs In Patients With Connective Tissue Disorders
4:48 PM - 4:53 PM
Wednesday, November 20, 2024
Session ModeratorSESSION 44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICSPresenterSESSION 44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICSIn Patients With AAAs From Genetic Aortopathy (Heritable Aortic Disease): Is Active Exercise Beneficial Or Harmful
2:12 PM - 2:17 PM
Friday, November 22, 2024
PresenterSESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMSHow To Use Motor Evoked Potentials (MEPs) To Decrease The Incidence Of SCI After Open And Endo TAAA Repairs: What Else Is Important
7:04 AM - 7:09 AM
PresenterSESSION 93: BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
2:54 PM - 2:59 PM
![](/faculty_photos_large/1897.jpg)
Jan D. Blankensteijn, MDAssociate Professor of Vascular Surgery
Amsterdam UMC
Amsterdam, The Netherlands
JAN D. BLANKENSTEIJN, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVARUpdate On Long-Term Results From The Dream RCT Comparing EVAR With Open Repair For AAAs Suitable For Both: Adverse Neck Anatomy (Short, Wide, Angulated) Was Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: Neck Dilatation Only Occurs After Open Repair And In EVARs With Self-Expanding Endografts: How Should This Influence Today’s Treatment
2:00 PM - 2:05 PM
![](/faculty_photos_large/2518.jpg)
John Blebea, MD, MBAClinical Professor of Surgery
Central Michigan University College of Medicine
Clinical Professor of Vascular Surgery
Central Michigan University
Saginaw, Michigan
JOHN BLEBEA, MD, MBA - SCHEDULE FOR VEITHsymposium™
Thursday, November 21, 2024
PresenterSESSION 69: SUPERFICIAL VEIN TREATMENT STRATEGIES IVForecast For Venous Reimbursement 2025
1:37 PM - 1:42 PM
PresenterSESSION 71: SUPERFICIAL VEIN TREATMENT STRATEGIES VIMechanical Chemically Assisted Ablation Of Varicose Veins For Venous Insufficiency: American Vein And Lymphatic Society Position Statement
4:25 PM - 4:30 PM
MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
CONTROVERSIES IN VENOUS DISEASE MANAGEMENT
WEDNESDAY, NOVEMBER 20, 2024
PRESENTER
11:55 AM - 12:00 PM
Most Venous Interventions Should Be Performed In A Hospital
![](/faculty_photos_large/3758.jpg)
Erwin Blessing, MDProfessor
University Hospital Hamburg-Eppendorf
Clinical Director
University Heart and Vascular Center
Hamburg, Germany
ERWIN BLESSING, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 21: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTSTechnical Tips For Vessel Prep For DCBs Or DESs: It Is Different And Not Simple: How To Do It And How Important Is It
3:00 PM - 3:05 PM
PresenterSESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTSExperience With >1500 Retrograde Recanalization For Chronic Total Occlusions (CTOs); What Predicts Technical Success And What Predicts Periprocedural Complications: Are Re-Entry Devices Ever Helpful
5:12 PM - 5:17 PM
Wednesday, November 20, 2024
PresenterSESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” Technical Tips For DVA: The Most Important Part Starts After The Procedure
1:54 PM - 1:59 PM
Thursday, November 21, 2024
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27) Advantages Of Supera VMI Stent For Complex FemPop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position
2:54 PM - 2:59 PM
![](/faculty_photos_large/2826.jpg)
Dittmar Boeckler, MDProfessor of Surgery
University of Heidelberg
Prof, Dr, Med
University Hospital of Heidelberg
Heidelberg, Germany
DITTMAR BOECKLER, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session ModeratorSESSION 6: MORE ABOUT TBADS, AAAS AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGS) AND GUIDELINESWednesday, November 20, 2024
PresenterSESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTSPreservation Of Left Subclavian Artery In TEVAR With Off-The-Shelf Branch Stentgraft Technology
1:08 PM - 1:16 PM
Thursday, November 21, 2024
PresenterSESSION 53: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS Cancer Incidence After Lower Extremity Bypass Surgery: How Does It Affect Long-Term Outcome In Patients With CLTI: Why The Relationship With Cancer Exists
4:06 PM - 4:11 PM
Friday, November 22, 2024
PresenterSESSION 94: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA Vascular Injuries After Blunt Abdominal Trauma: Diagnosis And Management: When Endo, When Open Treatment
3:52 PM - 3:57 PM
![](/faculty_photos_large/3883.jpg)
Michel J. Bosiers, MD Doctor
University Hospital Bern
Senior Consultant
University Hospital Bern
Bern, Switzerland
Oscar H. Bottini, MDProfessor of Surgery
Germany Hospital of Buenos Aires
Clinical Hospital Buenos Aires University
Buenos Aires University
Buenos Aires, Argentina
![](/faculty_photos_large/3478.jpg)
Jonathan R. Boyle, MD, MA (Cantab) FRCSAffiliate Assistant Professor
Department of Surgery, Cambridge University
Consultant Vascular Surgeon & Affiliate Assistant Professor
Cambridge University Hospitals NHS Trust
Cambridge, United Kingdom
![](/faculty_photos_large/3770.jpg)
Kursat A. Bozkurt, MDProfessor
Istanbul University Cerrahpasa Medical Faculty
Dr
Department of Cardiovascular Surgery
Istanbul, Turkey
Andrew W. Bradbury, MD, FRCSEdSampson Gamgee Professor (Emeritus) of Vascular Surgery
University of Birmingham
Consultant Vascular and Endovascular Surgeon
West Midland Vascular (UK) Ltd.
Birmingham, United Kingdom
Daniela Branzan, MDProfessor of Vascular Surgery
Technical University Munich
Head of the Clinic for Vascular and Endovascular Surgery
University Hospital of TUM
Munich, Germany
![](/faculty_photos_large/4222.jpg)
Clayton J. Brinster, MDAssociate Professor
University of Chicago Medical Center
Co-Director, Center for Aortic Diseases
University of Chicago Medical Center
Chicago, Illinois
![](/faculty_photos_large/3348.jpg)
Marianne Brodmann, MDProfessor
Medical University Graz
Professor
Medical University Graz
Graz, Austria
MARIANNE BRODMANN, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session ModeratorSESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTIWednesday, November 20, 2024
PresenterSESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI Is The Open Surgery First Or Endovascular First Approach Controversy Still Alive For CLTI: What Percentage Of An Interventionalist's Patients Should Be Treated First By Open Surgery
7:10 AM - 7:15 AM
PresenterSESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc.: When Is The Angiosome Concept Helpful; When Not
4:16 PM - 4:21 PM
PresenterSESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS How Should We Move Forward With Limus Coated Devices After FDA Has Cleared Paclitaxel Coated Devices: Are There Promising Results Currently With Limus Coated DCBs
10:18 AM - 10:23 AM
PresenterSESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS Below-The-Ankle Endo Interventions In 2024: Techniques, Devices And Should Balloons Be Drug Coated Or Not
11:48 AM - 11:53 AM
PresenterSESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN New Findings From The VOYAGER PAD And COMPASS RCTs With Low Dose Rivaroxaban (Xarelto [Janssen/J&J]) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open)
6:52 AM - 6:57 AM
Thursday, November 21, 2024
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27) A New More Complex Device For Treating Calcified Arterial Lesions With Lithotripsy (From BOLT Medical): How Does It Work And Advantages
2:12 PM - 2:17 PM
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27) An Update On The Soundbite Technology For Traversing And Treating Calcified Arterial Lesions: How Does It Work, Advantages, And Clinical Experience
2:30 PM - 2:35 PM
![](/faculty_photos_large/2306.jpg)
Allan L. Brook, MDProfessor of Radiology and Neurosurgery
Albert Einstein College of Medicine
Director, Interventional Neuroradiology
Montefiore Medical Center
Bronx, New York
![](/faculty_photos_large/2667.jpg)
Thomas G. Brott, MDProfessor of Neurology
Mayo Clinic College of Medicine
Neurologist
Mayo Clinic
Jacksonville, Florida
THOMAS G. BROTT, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session ModeratorSESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING Thursday, November 21, 2024
Session ModeratorSESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDSPresenterSESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDSCarotid Artery Disease: New Trials And Best Literature 2023
11:01 AM - 11:08 AM
Friday, November 22, 2024
Session ModeratorSESSION 81: MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION PresenterSESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONSDEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter
10:42 AM - 10:47 AM
PresenterSESSION 83: MORE HOT CAROTID AND SUBCLAVIAN TOPICS: UPDATES ON KEY CAROTID RCTSUpdate On CREST 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For Asymptomatic Carotid Stenosis (ACS): Recruitment And Findings To Date: Why Not Present The 30-Day And 1-Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS Or CEA, Wouldn’t This Remove Justification For Invasive Treatment Of ACS Until A Benefit Was Shown
1:06 PM - 1:11 PM
![](/faculty_photos_large/2876.jpg)
Kellie R. Brown, MDProfessor
The Medical College of Wisconsin
Senior Medical Director
Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin
![](/faculty_photos_large/1901.jpg)
O. William Brown, MD, JDProfessor of Surgery
Oakland University William Beaumont School of Medicine and Wayne State Univ
Adjunct Professor of Law
Michigan State University College of Law
Chief, Section of Vascular Surgery
William Beaumont Hospital
William Beaumont Hospital
Royal Oak, Michigan
![](/faculty_photos_large/2395.jpg)
Elchanan Bruckheimer, MBBSDirector, Pediatric Cardiac Catheterization
Schneider Children's Medical Center Israel
Petah-Tikva, Israel
ELCHANAN BRUCKHEIMER, MBBS - SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2024
PresenterSESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT Update On The Experience With BeGrafts (From Bentley), A Balloon Expandable Covered Stent For Treating Aortic Coarctations, Aneurysms And Midaortic Syndrome: Advantages And Limitations
7:32 AM - 7:37 AM
Thursday, November 21, 2024
PresenterSESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC. Novelrad Percutaneous Endovascular Suturing Device: How Does It Work And Clinical Experience
4:36 PM - 4:41 PM
![](/faculty_photos_large/4458.jpg)
![](/faculty_photos_large/3463.jpg)
Richard Bulbulia, MA, MD, FRCSProfessor
CTSU, Nuffield Department of Population Health, University of Oxford
Consultant Vascular Surgeon
Gloucestershire Royal Hospital
Oxford, United Kingdom
RICHARD BULBULIA, MA, MD, FRCS - SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2024
PresenterSESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN The Risk Of Arteriosclerosis And Its Complications Are Increased By LDL Cholesterol (LDL-C) Levels, Elevated Lp(a) And Inflammation: What Are The Best Medical Strategies To Decrease These Parameters: Statins, Adjunctive LDL-C Lowering Drugs Inclisiran, Bempedoic Acid, Ezetimibe, PCSK-9 Inhibitors, Lepodisiran, Colchicine, Olezarsen, Etc.) And Anti-Inflammatories: How They Should Be Administered
7:16 AM - 7:21 AM
Friday, November 22, 2024
PresenterSESSION 83: MORE HOT CAROTID AND SUBCLAVIAN TOPICS: UPDATES ON KEY CAROTID RCTSUpdate On ACST-2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates Up To 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT
1:24 PM - 1:29 PM
PresenterSESSION 93: BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc.
3:30 PM - 3:35 PM
![](/faculty_photos_large/2517.jpg)
Ruth L. Bush, MD, MPHProfessor of Surgery
John Sealy School of Medicine - UTMB
Vascular Surgeon
UTMB
Galveston, Texas
Jacques Busquet, MDCardio-Vascular and Endovascular Surgeon
The Vivalto Foundation Group
Coordinator, Department of Vascular Surgery
Clinique Val D'Or Saint Cloud
Paris, France